Santell L, Marotti K R, Levin E G
Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA,
Brain Res. 1999 Jan 16;816(1):258-65. doi: 10.1016/s0006-8993(98)01054-3.
Plasma levels of tissue plasminogen activator (tPA) increase rapidly in response to specific vasoactive agents, trauma, and neural stimulation. This response has been attributed to acute release of tPA from stored pools within the vascular endothelium and from catecholamine storage vesicles of chromaffin cells. We have tested directly whether tPA can be sorted into the regulated secretory pathway using the murine pituitary-derived neuroendocrine cell line AtT-20 transfected with tPA cDNA. Clones of AtT-20 cells expressing tPA were isolated, and targeting of tPA into the regulated secretory pathway was demonstrated by (1) stimulation of tPA secretion with 8-bromo-cAMP, the secretagogue which promotes the release of dense granule contents; (2) colocalization with ACTH, an endogenous protein that is stored in dense core granules; and (3) retention of newly synthesized tPA in the cell for prolonged periods of time. Laser scanning confocal microscopy analysis of cells immunostained with antibodies to tPA and ACTH showed colocalization at the tips of the neuritic processes under the cytoplasmic membrane, a region where dense granules are known to migrate after maturation. Treatment of the cells with 5 mM 8-bromo-cAMP for 30 min resulted in a 2.41+/-0.36-fold increase in tPA secretion. Both the magnitude of the stimulatory effect and the fraction of the intracellular tPA released were the same regardless of the tPA expression level in the various clones. Pulse-chase experiments showed that a portion of newly synthesized tPA is retained in the cell for at least 4 h and is released into the culture medium in response to 8-bromo-cAMP. These studies indicate that tPA, under the appropriate conditions, can be targeted into the regulated secretory pathway and can be stored for later release by cellular stimuli.
组织型纤溶酶原激活物(tPA)的血浆水平会因特定血管活性物质、创伤和神经刺激而迅速升高。这种反应归因于tPA从血管内皮细胞内的储存池以及嗜铬细胞的儿茶酚胺储存囊泡中急性释放。我们直接测试了使用转染了tPA cDNA的小鼠垂体来源的神经内分泌细胞系AtT-20,tPA是否能够被分选进入调节性分泌途径。分离出表达tPA的AtT-20细胞克隆,并通过以下方式证明tPA进入调节性分泌途径:(1)用8-溴-cAMP刺激tPA分泌,8-溴-cAMP是促进致密颗粒内容物释放的促分泌剂;(2)与促肾上腺皮质激素(ACTH)共定位,ACTH是一种储存在致密核心颗粒中的内源性蛋白质;(3)新合成的tPA在细胞内长时间保留。用抗tPA和ACTH抗体免疫染色的细胞的激光扫描共聚焦显微镜分析显示,在细胞质膜下的神经突末端共定位,已知致密颗粒成熟后会迁移到该区域。用5 mM 8-溴-cAMP处理细胞30分钟导致tPA分泌增加2.41±0.36倍。无论各个克隆中tPA的表达水平如何,刺激作用的幅度和释放的细胞内tPA的比例都是相同的。脉冲追踪实验表明,新合成的tPA的一部分在细胞内保留至少4小时,并在8-溴-cAMP的作用下释放到培养基中。这些研究表明,在适当条件下,tPA可以被靶向进入调节性分泌途径,并可以储存起来以供细胞刺激后释放。